Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371399 | Bioorganic & Medicinal Chemistry Letters | 2011 | 5 Pages |
Abstract
The discovery and evaluation of potent and long-acting oral sulfonamidopyrrolidin-2-one factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs are described. Unexpected selectivity issues versus tissue plasminogen activator in the former series were addressed in the later, delivering a robust candidate for progression towards clinical studies.
Graphical abstractThe discovery of potent and long-acting series of orally available factor Xa inhibitors with tetrahydroisoquinoline and benzazepine motifs is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Nigel S. Watson, Carl Adams, David Belton, David Brown, Cynthia L. Burns-Kurtis, Laiq Chaudry, Chuen Chan, Máire A. Convery, David E. Davies, Anne M. Exall, John D. Harling, Stephanie Irvine, Wendy R. Irving, Savvas Kleanthous, Iain M. McLay,